Study protocol to test the efficacy of self-administration of dexmedetomidine sedative therapy on anxiety, delirium, and ventilator days in critically ill mechanically ventilated patients: an open-label randomized clinical trial

被引:0
|
作者
Linda L. Chlan
Craig R. Weinert
Mary Fran Tracy
Debra J. Skaar
Ognjen Gajic
Jessica Ask
Jay Mandrekar
机构
[1] Mayo Clinic,
[2] University of Minnesota,undefined
来源
Trials | / 23卷
关键词
Mechanical ventilation; Sedation; Anxiety; Clinical trial; Intensive care;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 26 条
  • [21] Pharmacokinetics, SAfety/tolerability, and EFficacy of high-dose RIFampicin in tuberculosis-HIV co-infected patients on efavirenz- or dolutegravir-based antiretroviral therapy: study protocol for an open-label, phase II clinical trial (SAEFRIF)
    Ruth Nabisere
    Joseph Musaazi
    Paolo Denti
    Florence Aber
    Mohammed Lamorde
    Kelly E. Dooley
    Rob Aarnoutse
    Derek J. Sloan
    Christine Sekaggya-Wiltshire
    Trials, 21
  • [22] Study Protocol for a Prospective, Multicenter, Randomized, Open-Label, Parallel-Group Clinical Trial Comparing the Efficacy and Safety of a Needle-Free Insulin Injector and a Conventional Insulin Pen in Controlling Blood Glucose Concentrations in Chinese Patients with Type 2 Diabetes Mellitus (The FREE Study)
    Ji, LiNong
    Chen, LiMing
    Wang, YanGang
    Ma, ZhongShu
    Ran, XingWu
    Sun, ZiLin
    Xu, XiangJin
    Wang, GuiXia
    Guo, LiXin
    Shan, ZhongYan
    ADVANCES IN THERAPY, 2019, 36 (06) : 1485 - 1496
  • [23] Efficacy and safety of selective JAK 1 inhibitor filgotinib in active rheumatoid arthritis patients with inadequate response to methotrexate: comparative study with filgotinib and tocilizumab examined by clinical index as well as musculoskeletal ultrasound assessment (TRANSFORM study): study protocol for a randomized, open-label, parallel-group, multicenter, and non-inferiority clinical trial
    Shimizu, Toshimasa
    Kawashiri, Shin-ya
    Morimoto, Shimpei
    Kawazoe, Yurika
    Kuroda, Shohei
    Kawasaki, Rina
    Ito, Yasuko
    Kiya, Rieko
    Sato, Shuntaro
    Yamamoto, Hiroshi
    Kawakami, Atsushi
    TRIALS, 2023, 24 (01)
  • [24] Efficacy and safety of selective JAK 1 inhibitor filgotinib in active rheumatoid arthritis patients with inadequate response to methotrexate: comparative study with filgotinib and tocilizumab examined by clinical index as well as musculoskeletal ultrasound assessment (TRANSFORM study): study protocol for a randomized, open-label, parallel-group, multicenter, and non-inferiority clinical trial
    Toshimasa Shimizu
    Shin-ya Kawashiri
    Shimpei Morimoto
    Yurika Kawazoe
    Shohei Kuroda
    Rina Kawasaki
    Yasuko Ito
    Rieko Kiya
    Shuntaro Sato
    Hiroshi Yamamoto
    Atsushi Kawakami
    Trials, 24
  • [25] A multicenter, open-label, randomized, proof-of-concept phase II clinical trial to assess the efficacy and safety of icatibant in patients infected with SARS-CoV-2 (COVID-19) and admitted to hospital units without invasive mechanical ventilation: study protocol (ICAT-COVID)
    Pierre Malchair
    Aurema Otero
    Jordi Giol
    Xavier Solanich
    Thiago Carnaval
    Alonso Fernández-Nistal
    Ana Sánchez-Gabriel
    Carmen Montoto
    Ramon Lleonart
    Sebastián Videla
    Trials, 23
  • [26] A multicenter, open-label, randomized, proof-of-concept phase II clinical trial to assess the efficacy and safety of icatibant n patients infected with SARS-CoV-2 (COVID-19) and admitted to hospital units without invasive mechanical ventilation: study protocol (ICAT-COVID)
    Malchair, Pierre
    Otero, Aurema
    Giol, Jordi
    Solanich, Xavier
    Carnaval, Thiago
    Fernandez-Nistal, Alonso
    Sanchez-Gabriel, Ana
    Montoto, Carmen
    Lleonart, Ramon
    Videla, Sebastian
    TRIALS, 2022, 23 (01)